Publications by authors named "Ismail Elchagea"

Claim this Profile
A
Ambovex(®) as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial.
Hosny Salama, Hassan Ahmad, Ismail Elchagea, Abdel Rahman Zekri, Eman Medhat

J Hepatocell Carcinoma· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis